News
Swiss company to produce Russian Sputnik coronavirus vaccine in Italy
The Russian Direct Investment Fund (RDIF) is set to cooperate with Swiss-based Adienne Pharma & Biotech for Sputnik V coronavirus vaccine production in Italy, chief executive of RDIF Kirill Dmitriev said.
"We are holding talks with the government of Italy....
News
Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes
Eli Lilly and Company and Biolojic Design Ltd., a biotechnology company that computationally designs functional antibodies, announced a research collaboration and license agreement that will leverage Biolojic's AI-based multibody platform to discover and develop a potential novel antibody-based therapy...
News
Johnson & Johnson COVID-19 Vaccine Granted Authorization under Interim Order by Health Canada For Emergency Use
Johnson & Johnson announced that Health Canada has granted an Interim Order (IO) authorization for its single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and...
Clinical Trials
Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. announced initiation of study VLA15-221. The VLA15-221 study builds on previous positive Phase 2 studies, incorporates new dose regimens and is...
Clinical Trials
LSK Global PS Adopts Veeva Vault Clinical Applications to Streamline Global Trial Processes
Veeva Systems announced that LSK Global Pharma Services Co. Ltd, a leading Korean contract research organization (CRO), has adopted Veeva Vault eTMF, Veeva Vault CTMS, and Veeva SiteVault Free. With Veeva Vault Clinical applications, LSK Global PS can streamline...
News
Vetter establishes office in China to better serve the needs of its growing customer base worldwide
Germany based Vetter, one of the global leaders in prefilled drug-delivery systems, has announced the opening of a new business entity in Shanghai, China. The new office, now its fourth in the Asia Pacific (APAC) region, will help increase...
News
Natco’s marketing partner gets USFDA nod for cancer treatment drug
Natco Pharma said its marketing partner Breckenridge Pharmaceutical Inc has received final approval from the US health regulator for cancer treatment drug Everolimus. The approved product is a generic for Afinitor.
"Breckenridge Pharmaceutical Inc (BPI) has received final approval for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.